Comparative assessment of different ivermectin and doramectin formulations for mange control in grazing steers

CANTON, CANDELA; MUCHIUT, SEBASTIÁN; DOMINGUEZ, MARÍA PAULA; LANUSSE, CARLOS; ALVAREZ, LUIS IGNACIO; LIFSCHITZ, ADRIÁN

VETERINARY PARASITOLOGY

ELSEVIER SCIENCE BV

Año: 2023 vol. 316

0304-4017

Psoroptic mange causes relevant losses of productivity in cattle. Macrocyclic lactones are one of the mainpharmacological tools recommended for controlling it. The aim of the current work was to compare the relationship between the pharmacokinetic behavior and the effectiveness of both ivermectin (IVM) and doramectin(DRM) following their administration as either the traditional (1 %) or long-acting (3.15–3.5 %) injectableformulations to cattle naturally infected with Psoroptes ovis. The overall work involved three trials (1, 2 and 3)carried out on commercial beef cattle farms (grazing systems). In Trial 1, 20 grazing steers with active mangeinfection were allocated into 2 groups (n = 10) and treated subcutaneously (SC) with either IVM (1 %) or DRM(1%) at 0.2 mg/kg. In Trial 2, 16 grazing steers with active mange divided in 2 groups (n = 8) were treated SCwith either IVM 1 % (0.2 mg/kg) or IVM 3.15 % long-acting (0.63 mg/kg). In Trial 3, 2 groups of mange infectedsteers (n = 8) were treated SC with either IVM 3.15 % (0.63 mg/kg) or DRM 3.5 % (0.7 mg/kg). Blood sampleswere collected of each experimental group and the drug systemic availability was estimated by measuring ofIVM/DRM concentrations by HPLC. Skin scraping samples were collected from each animal and mites werecounted at 14, 21 and 28 days post-treatment. In Trial 1, the mite density score on day 14 was signifcantly lowerfor DRM (0.60) compared to IVM (1.80) (P = 0.019). Based on the number of animals clinically cured (negativeto the presence of mites), the effcacy of DRM was higher (80 %) than that obtained for IVM (10 %) (P < 0.05).DRM systemic exposure measured as AUC was 1.37-fold higher compared to IVM. In Trial 2, even though IVMexposure was signifcantly greater after the long-acting (3.15 %) compared to the traditional formulation (1 %),none of the treatments signifcantly reduced the mite density score, with a percentage of animals cured between0 % and 37.5 % after both IVM treatments. In Trial 3, the 100 % of cured animals were achieved at day 21 (IVM3.15 %) and at day 28 (DRM 3.5 %) post-treatment. In conclusion, DRM treatment could offer some therapeuticadvantages in feld situations where IVM fails to control mange. Depending on the level of susceptibility of themite population, long-acting pharmaceutical formulations can be useful to control Psoroptic mange in cattle. Theuse of macrocyclic lactones for mange control in cattle should be based on appropriate diagnosis on each individual farm.